The 33rd BVMA Symposium in Munich brought together an extraordinary cross-section of Germany’s clinical research landscape including industry leaders, regulatory agencies, CROs, sponsors, NGOs, and government representatives. For entimo’s CEO, Marc Jantke, it was his first time stepping into what some attendees call a “class reunion.” As it turned out, the nickname was more accurate than he expected.